European Biotech Company Implements a Quality Management System Tailored for Agile SaaS Development

Client Challenge

ELEM Biotech, a European biotech company with a Software-as-a-Service (SaaS) platform in development, sought support to implement a Quality Management System (QMS) compliant with ISO 13485 and IEC 62304:2006. This step was necessary to support their SaaS use in highly regulated healthcare environments and ensure their software meets the highest safety and quality standards. A robust QMS would allow the company to demonstrate the quality, safety, and reliability of its technology to its clients, healthcare providers, sponsors, and regulatory bodies, provide competitive differentiation, and reduce liability risks through documented risk analysis and mitigation strategies.

These quality standards were particularly valuable for a SaaS platform specifically focused on making medical testing and clinical trials safer. The client wanted to ensure software reliability, data integrity, and patient safety, critical elements for all medical technology stakeholders.

ELEM Biotech looked for a QMS implementation process that would meet mandatory regulatory requirements, allow them to maintain their agile software development practices, and avoid disruption of internal processes.

In light of the complexity and innovative nature of ELEM’s solutions, ELEM Biotech chose Alira Health for its high level of professionalism, collaborative working style, and capability to co-develop a QMS tailored to ELEM’s specific context. Alira Health brought strong regulatory know-how and hands-on experience in medical device and software regulations, enabling the effective integration of ELEM’s agile software development practices in full regulatory compliance.

Our Approach

Alira Health’s Regulatory Medtech team designed a modern, streamlined methodology to implement an ISO 13485 and IEC 62304 compliant QMS, tailored to a SaaS and agile development environment.

Successful QMS implementation goes beyond simply identifying mandatory regulatory requirements. Initially, the team assessed ELEM Biotech’s existing internal procedures, workflows, and development practices to reduce operational disruption and ensure adoption and sustainability. They aligned regulatory requirements with these processes wherever possible and developed customized templates and documentation to ensure compliance.

The team aligned regulatory expectations, designed for agile methodologies that focus on continuous integration and deployment. The team also provided hands-on support to structure documentation, traceability, and risk management in a way that preserved agility while meeting regulatory standards.

Regular, iterative work sessions enabled the Alira Health and ELEM Biotech teams to refine documentation and methodologies collaboratively, resulting in a sustainable and efficient QMS that supported long-term compliance.

Alira Health also delivered tailored trainings to ensure that ELEM Biotech’s team understood the regulatory requirements and how to integrate them into their development processes.

ELEM Biotech, with Alira Health’s support, implemented an effective QMS fully aligned with ISO 13485:2016 and IEC 62304 and adapted to a SaaS environment. They expressed satisfaction with the implementation of the QMS and the software requirements and noted that they aligned well with their internal procedures. They also appreciated the minimal disruption to the current workload.

Outcomes

ELEM Biotech, with Alira Health’s support, implemented an effective QMS fully aligned with ISO 13485:2016 and IEC 62304:2006 and adapted to a SaaS environment. They expressed satisfaction with the implementation of the QMS and the software requirements and noted that they aligned well with their internal procedures. They also appreciated the minimal disruption to the current workload.

Success Factors

The success of this project was driven by a tailored, client-centric approach aligned with the product, organization size, and regulatory pathway, ensuring an efficient and compliant QMS.

Alira Health developed a modern and pragmatic compliance framework that aligned regulatory requirements with agile development practices by leveraging multidisciplinary expertise across quality, regulatory, and software domains. Finally, continuous collaborative iteration through regular follow-ups allowed Alira Health to refine the approach based on ELEM Biotech’s feedback. The result was a QMS that was mutually agreed upon and sustainable in practice.